Medullary thyroid carcinoma and multiple endocrine neoplasia type 2

被引：0
|
作者：
Hiroshi Takami
机构：
[1] Teikyo University School of Medicine,Department of Surgery
来源：
Endocrine Pathology | 2003年 / 14卷
关键词：
Calcitonin; medullary thyroid carcinoma; multiple endocrine neoplasia; protooncogene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Medullary thyroid carcinoma (MTC) occurs as both a sporadic and an inherited disease. MTC is a consistent feature of multiple endocrine neoplasia (MEN) 2A, MEN 2B, and familial non-MEN MTC (FMTC). Plasma calcitonin is a sensitive and specific marker for the presence of MTC. Genetic testing can identify mutant gene carriers, and prophylactic total thyroidectomy should be carried out in patients with the mutant gene. The outcome of MTC is progressively worse in FMTC, MEN 2A, sporadic MTC, and MEN 2B, and MEN 2B has been found to have the worst prognosis. There is a significant genotype-phenotype correlation, which allows a more sensitive individualized approach to the timing and extent of prophylactic thyroidectomy.
引用
收藏
页码：123 / 131
页数：8
相关论文
共 50 条
  • [21] Brain metastases from medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 2A
    Pitale, SU
    Melian, E
    Thomas, C
    Moley, JF
    Origitano, T
    Sizemore, GW
    THYROID, 1999, 9 (11) : 1123 - 1125
  • [22] RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma
    Marsh, DJ
    Mulligan, LM
    Eng, C
    HORMONE RESEARCH, 1997, 47 (4-6) : 168 - 178
  • [23] PRESYMPTOMATIC SCREENING FOR MEDULLARY-THYROID CARCINOMA IN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A
    FRILLING, A
    ROHER, HD
    PONDER, BAJ
    WORLD JOURNAL OF SURGERY, 1994, 18 (04) : 577 - 582
  • [24] UNUSUAL CASE OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A SYNDROME WITHOUT MEDULLARY THYROID CARCINOMA
    Tyer, Nicole M.
    Braunstein, Glenn D.
    Frishberg, David
    ENDOCRINE PRACTICE, 2011, 17 (02) : E4 - E7
  • [25] RET PROTOONCOGENE MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 AND MEDULLARY-THYROID CARCINOMA
    COTE, GJ
    WOHLLK, N
    EVANS, D
    GOEPFERT, H
    GAGEL, RF
    BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1995, 9 (03): : 609 - 630
  • [26] Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2
    Wohllk, N
    Cote, GJ
    Evans, DB
    Goepfert, H
    Ordonez, NG
    Gagel, RF
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (01) : 1 - +
  • [27] Gene sequencing as a diagnostic tool in multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma
    Martinez, JJ
    Bailey, A
    Hamdan, H
    Fisher, DA
    Leon, JA
    CLINICAL CHEMISTRY, 1996, 42 (11) : 6 - 6
  • [28] THYROID MEDULLARY CARCINOMA WITH THYROGLOBULIN IMMUNOREACTIVITY IN SPORADIC MULTIPLE ENDOCRINE NEOPLASIA TYPE 2-B
    KOVACS, CS
    MASE, RM
    KOVACS, K
    NGUYEN, GK
    CHIK, CL
    CANCER, 1994, 74 (03) : 928 - 932
  • [29] Choroidal metastasis from medullary thyroid carcinoma in multiple endocrine neoplasia
    Shields, JA
    Shields, CL
    Perez, N
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (04) : 607 - 609
  • [30] Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient
    Sarathi, Vijaya
    Bandgar, Tushar R.
    Menon, Padma S.
    Shah, Nalini S.
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (08) : 533 - 535
12345